FDA Orange Book · active-ingredient family
Chlorothiazide sodium
Chlorothiazide sodium is approved as 1 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:DIURIL · NDA 011145
1
Brand (NDA)
6
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| DIURILRLD | RISING | NDA 011145 | — | Approved Prior to Jan 1, 1982 |
Generic (ANDA) products (6)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CHLOROTHIAZIDE SODIUM | GLAND | ANDA 218630 | AP | Oct 03, 2024 | |
| CHLOROTHIAZIDE SODIUM | SAGENT PHARMS INC | ANDA 202462 | AP | May 29, 2015 | |
| CHLOROTHIAZIDE SODIUM | RK PHARMA | ANDA 202493 | — | Jun 18, 2014 | |
| CHLOROTHIAZIDE SODIUM | AM REGENT | ANDA 202561 | AP | Apr 22, 2013 | |
| CHLOROTHIAZIDE SODIUM | SUN PHARM | ANDA 091546 | AP | Jul 26, 2011 | |
| CHLOROTHIAZIDE SODIUM | FRESENIUS KABI USA | ANDA 090896 | AP | Oct 16, 2009 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Chlorothiazide sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

